Receive CPI's latest news delivered to your inbox.Sign up to our Mailing List
The UK has a strong history of academic research and a rich landscape of capability and infrastructure in biologics, but in the face of increasing global competition and investment, interventions are required to anchor this high value sector in the UK.
CPI collaborates with large corporates, SME’s, academia and charities to enable the delivery of innovative manufacturing solutions to accelerate the growth of new and emerging biologic medicines. Through these collaborations we develop, prove and commercialise innovative new processes and technologies that enable the cost effective, safe and high quality manufacture of life changing biologic therapies.
CPI is focussed on three key themes:
CPI established the UK’s National Biologics Manufacturing Centre in 2015 with funding from the Government’s Department for Business Innovation and Skills. The state-of-the-art facility is equipped with advanced technologies for upstream and downstream processing, high throughput process development, comprehensive analytical characterisation and capabilities for formulation, fill and finish.
The facility has over 700m2 of flexible laboratories designed to handle BSL1 and BSL2 organisms. We can run whole bioprocess development programmes in our laboratories as well as developing “GMP ready” processes in a series of GMP proving clean rooms. The flexible design of the facility enables equipment expansion and reconfiguration to support specific projects.
The CPI team bring significant expertise in all aspects of biopharmaceutical development and manufacture including mammalian and microbial process development, process scale-up and technology transfer, advanced bioanalytical development, new technology development and evaluation, advanced experimental design and multivariate data analysis.
CPI supports the UK biopharmaceutical industry by engaging in a variety of collaborative work programmes to support process innovation and facilitate the development and adoption of new manufacturing and analytical technologies. Our capabilities and expertise in high throughput and novel process development enables partners and clients to bring their products to market more quickly and with reduced risk. We support SMEs, large companies and universities to translate early, proof of concept stage research into industry and market-ready technologies. Clients can also access our facility and expertise on a fee for service basis.
The National Biologics Manufacturing Centre has been created to act as a central hub for the UK’s Biologics industry, hosting key events and research projects and providing a central facility to advance innovation in the industry